Search - tctmd.com

Displaying 1 - 20 of 115

Sort: Relevancy | Date

Presentation TCT 2024

Controlled Pulmonary Banding for Dilated Cardiomyopathy: the Restore Medical Approach

Presenter: Sean Pinney

October 28, 2024

Presentation NY Valves 2024

Controlled Pulmonary Banding for Dilated Cardiomyopathy: RESTORE Medical Clinical Results

Presenter: Elchanan Bruckheimer

June 05, 2024

News Daily News

Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer

L.A. McKeown

February 10, 2022

Presentation Cell Therapy 2013

REVIVE: Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy

Presenter: Amit N. Patel

January 22, 2013

Presentation TCT 2024

TCT 879: Perioperative and In-Hospital Outcomes of Dilated Cardiomyopathy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large Cross-Sectional Study Using National Inpatient Sample

Presenter: Ankur Singla

October 27, 2024

News Conference News AHA 2018

Remission, Not Cure: No Weaning Off Meds for Dilated Cardiomyopathy Patients, Says TRED-HF

Shelley Wood

November 11, 2018

Presentation

Catheter-DCM Study: Administration of Ixmyelocel-T in Dilated Cardiomyopathy

Presenter: J.H. Traverse

January 27, 2013

Presentation Cell Therapy 2012

REVIVE: Early Results of Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy

Presenter: Amit Patel

January 25, 2012

Presentation TVT 2013

Impact of Function MR on Outcomes in Ischemic and Idiopathic Dilated Cardiomyopathy: Major Culprit or Innocent Bystander?

Presenter: Maurice Sarano

June 14, 2013

Presentation TCT 2013

Effective Antegrade Cardiac Gene Therapy with VEGF-B167 for Pacing-induced Dilated Cardiomyopathy in a Pre-clinical Large Animal Model of Heart Failure

Presenter: Felix Woitek

October 29, 2013

Presentation TCT 2012

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

Presenter: Martyn Thomas

October 23, 2012

Presentation TCT 2014

TCT 150: First-in-Man Experience with Transendocardial Injections of Bone Marrow-Derived Mesenchymal Stem Cells in Idiopathic Dilated Cardiomyopathy: The MYOCYTE Trial

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Ricardo Sanz-Ruiz, MD

September 15, 2014

News Conference News ESC 2016

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Michael O'Riordan

August 28, 2016

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Conference News ESC Heart Failure 2025

TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal

Todd Neale

May 21, 2025

News Conference News HRS 2025

BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs

Todd Neale

May 02, 2025

News Daily News

Donor Hearts Fare Better With Novel Method After Circulatory Death

Michael O'Riordan

May 01, 2025

News Conference News HRS 2025

PRAETORIAN-XL: Fewer Major, Lead-Related Problems With Subcutaneous ICD

Todd Neale

April 29, 2025

Advertisement

Controlled Pulmonary Banding for Dilated Cardiomyopathy: the Restore Medical Approach

Controlled Pulmonary Banding for Dilated Cardiomyopathy: RESTORE Medical Clinical Results

Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer

REVIVE: Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy

TCT 879: Perioperative and In-Hospital Outcomes of Dilated Cardiomyopathy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large Cross-Sectional Study Using National Inpatient Sample

Remission, Not Cure: No Weaning Off Meds for Dilated Cardiomyopathy Patients, Says TRED-HF

Catheter-DCM Study: Administration of Ixmyelocel-T in Dilated Cardiomyopathy

REVIVE: Early Results of Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy

Impact of Function MR on Outcomes in Ischemic and Idiopathic Dilated Cardiomyopathy: Major Culprit or Innocent Bystander?

Effective Antegrade Cardiac Gene Therapy with VEGF-B167 for Pacing-induced Dilated Cardiomyopathy in a Pre-clinical Large Animal Model of Heart Failure

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

TCT 150: First-in-Man Experience with Transendocardial Injections of Bone Marrow-Derived Mesenchymal Stem Cells in Idiopathic Dilated Cardiomyopathy: The MYOCYTE Trial

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

CVD Still the Leading Cause of Death and Disease Globally

TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal

BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs

Donor Hearts Fare Better With Novel Method After Circulatory Death

PRAETORIAN-XL: Fewer Major, Lead-Related Problems With Subcutaneous ICD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content